^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    YL201

    i
    Other names: YL201
    Associations
    News
    Trials
    Company:
    MediLink
    Drug class:
    Topoisomerase I inhibitor, B7-H3-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials